Streetbeat News

Revenues

RAMP

LiveRamp has provided its financial outlook for fiscal year 2025, expecting revenue between $710 million and $730 million, representing an 8% to 11% increase. The company anticipates a GAAP operating loss of $8 million to $4 million and a non-GAAP operating income of $125 million to $129 million.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:10 pm

RAMP

LiveRamp expects Q1 FY25 revenue of $172 million, surpassing estimates of $166.235 million. The company anticipates a GAAP operating loss of $8 million and a non-GAAP operating income of $25 million.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:09 pm

PLUS

ePlus Inc. projects a revenue growth of 3.0%-6.0% for the fiscal year 2025.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:07 pm

RAMP

LiveRamp Holdings (NYSE:RAMP) reported Q4 2024 earnings of $0.25 per share, beating the analyst estimate of $0.19. Sales were $171.852 million, surpassing the $160.623 million estimate. Despite a year-over-year EPS decrease, sales increased by 15.63%.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:07 pm

PLUS

ePlus (NASDAQ:PLUS) reported Q4 2024 earnings per share of $0.93, missing the analyst estimate of $1.17 by 20.51%. However, the company reported sales of $554.5 million, beating the estimate of $537.833 million by 3.10% and showing a 12.66% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:06 pm

CYTK

RPRX

Cytokinetics and Royalty Pharma have entered a funding collaboration where Cytokinetics will receive $50 million upfront and is eligible to draw an additional $175 million within 12 months of Aficamten's approval. In return, Royalty Pharma will receive 4.5% of annual net sales of Aficamten up to $5 billion and 1% above $5 billion.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:02 pm

ABM

ABM has announced plans to expand its EV infrastructure capabilities to meet growing demand from clients for fleet electrification. The company has already installed over 30,000 EV ports nationwide and aims to further develop scalable solutions for commercial and public infrastructure fleets.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 8:02 pm

ORCL

Oracle (NYSE:ORCL) has outperformed the market over the past 20 years, producing an average annual return of 12.82%. A $1000 investment in ORCL 20 years ago would be worth $10,893.87 today. The article highlights the impact of compounded returns over time.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 8:01 pm

BMA

CEPU

GGAL

MELI

PAM

SUPV

Shares of US-listed Argentinian stocks are trading lower due to a reported decline in the March economic activity index year over year.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 7:53 pm

MSFT

Microsoft's Build event highlights significant advancements in AI-powered developer tools and Azure services. Key takeaways include the growth of Copilot Studio, the integration of GitHub with Azure, and the use of Azure AI by companies like TomTom.

Portfolio Pulse from Surbhi Jain

May 22, 2024 | 7:43 pm